LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
52.34 -0.74   -1.39%3.38%516,137754.0K

Market data is delayed by at least 20 minutes.
Market is closed. As of 03:59 PM ET 7/19/2013
 
 
 

Latest News Headlines for Sanofi SA

Approvals, FDA Response Letters, New Drug Applications, Collaborations, and Positive Opinions Boost Major Drug Portfolios - Research Report on Pfizer, Merck, GSK, AstraZeneca, and Sanofi
4 days 18 hours 28 minutes ago - PR Newswire via Dow Jones News
Editor Note: For more information about this release, please scroll to bottom NEW YORK, July 15, 2013 /PRNewswire/ -- Today, Wall Street Reports announced new research reports highlighting Pfizer Inc. (NYSE: PFE), Merck & Co. Inc. (NYSE: MRK), GlaxoSmithKline plc (NYSE: GSK), AstraZeneca PLC (NYSE: AZN), and Sanofi (NYSE: SNY). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
View more recent headlines
 
 
 
Company Background
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company based in France. The Company discovers, develops and distributes therapeutic solutions focused on patients' needs. The Company focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. The Company has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. The Company is active domestically and abroad, including other European countries, North and Latin Americas, Asia, Africa and Middle East. In December 2012, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc. In April 2013, the Company inaugurated its logistics platform in Casablanca, Morocco.

Bid/Size
-- / --
Ask/Size
-- / --
Price Open
52.00
Previous Close
53.08
Day High
52.56
Day Low
51.94
52wk High/Date
55.94 / 5/28/2013
52wk Low/Date
36.62 / 7/24/2012
% off 52wk High
-6.44%
% off 52wk Low
42.93%
Beta (5 Yr)
0.9
Market Capitalization
138.5B
Shares Outstanding
2.6B
Volatility Avg
39.18
EPS(TTM)
2.05
P/E Ratio
25.6x
Dividend Announcement
2/12/2013
Dividend Yield
3.38%
Ex-Date
5/6/2013
Date of Record
5/8/2013
Payable
1.7925 - ANN
Payable Date
6/5/2013
Last Trade as of 7/19/2013 4:02 PM ET
 
 
 

SNY Sanofi SA vs. Peers

Peers 
SNY
Sanofi SA
10.47%
Abbott Laboratories
14.45%
Bristol Myers Squibb Co.
35.59%
Eli Lilly & Co.
2.60%
SNY
Sanofi SA
3.42%
Abbott Laboratories
1.56%
Bristol Myers Squibb Co.
3.17%
Eli Lilly & Co.
3.87%
SNY
Sanofi SA
-1.39%
Abbott Laboratories
0.48%
Bristol Myers Squibb Co.
0.55%
Eli Lilly & Co.
1.36%
Compare these stocks